EAM

Exome Asset Management Portfolio holdings

AUM $170M
1-Year Est. Return 208.51%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+208.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$170M
AUM Growth
-$32.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1 +$4.1M
2 +$3.95M
3 +$3.91M
4
BSX icon
Boston Scientific
BSX
+$3.87M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$3.57M

Top Sells

1 +$5.49M
2 +$5.26M
3 +$4.5M
4
IMVT icon
Immunovant
IMVT
+$4.03M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$3.91M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
1
Praxis Precision Medicines
PRAX
$7.08B
$14.6M 8.62%
45,469
-12,653
COGT icon
2
Cogent Biosciences
COGT
$5.3B
$10.7M 6.31%
278,533
-27,035
ELVN icon
3
Enliven Therapeutics
ELVN
$2.11B
$8.63M 5.08%
220,091
-2,217
IONS icon
4
Ionis Pharmaceuticals
IONS
$12.3B
$8.26M 4.86%
110,064
-6,451
GH icon
5
Guardant Health
GH
$16.7B
$7.64M 4.5%
82,736
-15,446
CYTK icon
6
Cytokinetics
CYTK
$9.7B
$6.84M 4.02%
103,718
-21,031
LLY icon
7
Eli Lilly
LLY
$1.01T
$6.45M 3.8%
7,012
-840
ALMS
8
Alumis Inc
ALMS
$2.43B
$6.15M 3.62%
279,176
-13,074
BBIO icon
9
BridgeBio Pharma
BBIO
$13.2B
$5.01M 2.95%
67,492
-13,231
VERA icon
10
Vera Therapeutics
VERA
$2.32B
$4.63M 2.72%
114,991
-9,400
INSM icon
11
Insmed
INSM
$20.4B
$4.36M 2.56%
+26,651
ELV icon
12
Elevance Health
ELV
$90.2B
$4.3M 2.53%
14,677
-2,514
AGIO icon
13
Agios Pharmaceuticals
AGIO
$1.68B
$4.23M 2.49%
125,060
-11,882
UTHR icon
14
United Therapeutics
UTHR
$23.3B
$4.18M 2.46%
7,053
-632
MLTX icon
15
MoonLake Immunotherapeutics
MLTX
$1.32B
$4.01M 2.36%
+215,376
NTRA icon
16
Natera
NTRA
$30.8B
$3.73M 2.19%
18,650
RYTM icon
17
Rhythm Pharmaceuticals
RYTM
$5.93B
$3.53M 2.08%
+40,581
UNH icon
18
UnitedHealth
UNH
$363B
$3.48M 2.05%
12,862
+7,027
APLS
19
DELISTED
Apellis Pharmaceuticals
APLS
$3.44M 2.02%
85,517
-50,332
VSTM icon
20
Verastem
VSTM
$326M
$3.37M 1.99%
636,700
+234,957
TXG icon
21
10x Genomics
TXG
$3.94B
$3.27M 1.93%
154,194
-9,464
BSX icon
22
Boston Scientific
BSX
$72.2B
$3.03M 1.79%
+48,347
ALKS icon
23
Alkermes
ALKS
$7.13B
$2.97M 1.75%
+84,103
GLUE icon
24
Monte Rosa Therapeutics
GLUE
$1.38B
$2.95M 1.74%
+179,484
ISRG icon
25
Intuitive Surgical
ISRG
$149B
$2.93M 1.72%
6,358